Profound Medical (TSX:PRN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.35) by 45.71 percent. This is a 47.22 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $5.337 million which missed the analyst consensus estimate of $6.648 million by 19.72 percent. This is a 103.62 percent increase over sales of $2.621 million the same period last year.